Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Medicsight PLC announced that it has signed a preliminary agreement with the System Integration division of Toshiba Medical Systems for the resale of its MedicRead Colon and ColonCAD software solutions throughout Japan. Medicsight PLC (AIM:MDST) announced that it has signed a preliminary agreement with the System Integration division of Toshiba Medical Systems Corporation for the resale of its MedicRead Colon and ColonCAD software solutions throughout Japan.

Toshiba Medical Systems Corp. is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba will work with Medicsight to obtain MHLW approval in Japan. In addition, both companies have also identified the need for radiologists and gastroenterologists to be trained in the use of the software to help them to interpret CT colonography (CTC) images and rapidly identify suspicious regions for detailed evaluation. In late October Medicsight and Toshiba hosted CTC training workshops at the Japanese Digestive Disease Week (JDDW) conference in Kobe. The JDDW conference is the largest Gastroenterological congress of the year in Japan. Medicsight and Toshiba will continue to work together on similar market development initiatives in 2008 and beyond.

David Sumner, Chief Executive of Medicsight, commented: "We are delighted to be working with Toshiba, one of the worlds largest medical imaging solution providers. This agreement is timely as the recently announced positive outcomes of two major clinical trials are widely expected to accelerate the adoption of CTC (also known as virtual colonoscopy) as routine primary screening for colorectal cancer. Toshiba will help to promote the use of our MedicRead Colon and ColonCAD™ software to ease the workload of radiologists and to help them accurately identify colorectal polyps and tumours at an early stage when there is a good chance of successful treatment. We see this as bringing important benefits to both Japanese patients and the Japanese healthcare system alike."

Takashi Masuzawa, Chief Specialist of Toshiba System Integration development department, added: "We believe that the Medicsight advanced software solutions will augment the strong portfolio of Toshiba products and provide an opportunity to market the integrated PACS products to current and future customers. Both Medicsight and Toshiba view this agreement as the start of a long term relationship for CT colonography solution in Japan. It is the intent of this agreement to continue further development and licensing of joint Medicsight and Toshiba products through the Toshiba PACS channel."

Gen Iinuma, Head of Staffs, Diagnostic Radiology Division, National Cancer Center Hospital Tokyo, commented: "We have been working on the development of the Medicsight ColonCAD in collaboration with Professor Steve Halligan, University College Hospital, for some time now. This collaboration consists of a three year clinical programme, which when delivered upon will deliver 8 clinical studies to support both the regulatory and sales & marketing efforts of Medicsight and Toshiba. We have been delighted with the performance of the product and are very pleased that the Radiology community at large will soon have this additional software solution available to them to help combat this debilitating and potentially fatal disease.